Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Amgen is developing a GLP-1/GIP dual agonist called MariTide (currently in phase 3 trials expected to complete in 2027), which is administered as a once-monthly injection
doi: 10.2174/1573399816666200705210006
Cardiovascular factors: Obesity is associated with increased cardiovascular risk
High-dose biotin supplements may interfere with certain laboratory tests, so always inform healthcare providers about supplements you take before blood tests
From monocyte-derived macrophages to resident macrophages-how metabolism leads their way in cancer
PMCID: PMC3215082
US$ 28.12
US$ 22.91
US$ 28.00
US$ 26.85
US$ 24.50
